HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Michael Wells Selected Research

Polysaccharides (Glycans)

1/2023Hypoxia Controls the Glycome Signature and Galectin-8-Ligand Axis to Promote Protumorigenic Properties of Metastatic Melanoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Michael Wells Research Topics

Disease

6Neoplasms (Cancer)
01/2022 - 08/2002
3Wounds and Injuries (Trauma)
04/2024 - 01/2022
3Breast Neoplasms (Breast Cancer)
11/2023 - 02/2002
3Hypoxia (Hypoxemia)
01/2023 - 02/2002
2Critical Illness (Critically Ill)
04/2024 - 07/2021
2Glioma (Gliomas)
01/2022 - 01/2021
2Carcinogenesis
01/2022 - 01/2021
2Ectopic Pregnancy
07/2012 - 05/2012
1Heart Arrest (Cardiac Arrest)
04/2024
1Pulmonary Arterial Hypertension
12/2023
1Heart Failure
12/2023
1Pulmonary Edema
12/2023
1Scotoma (Scintillating Scotoma)
11/2023
1Macular Degeneration (Age-Related Maculopathy)
11/2023
1Tics (Tic)
01/2023
1Meningioma (Meningiomas)
01/2022
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2022
1Melanoma (Melanoma, Malignant)
01/2022
1Central Nervous System Diseases (CNS Diseases)
01/2022
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2022
1Hypersensitivity (Allergy)
12/2021
1Brain Neoplasms (Brain Tumor)
01/2021
1COVID-19
01/2021
1Psoriasis (Pustulosis Palmaris et Plantaris)
01/2020
1Reperfusion Injury
01/2020
1Pathologic Processes
01/2020
1Systemic Scleroderma (Systemic Sclerosis)
01/2019
1Paraganglioma (Paragangliomas)
01/2019
1Pathologic Dilatation (Ectasia)
01/2019
1Sclerosis
01/2019
1Premature Aging
01/2019
1Telangiectasis (Telangiectasia)
01/2019
1Hemorrhage
09/2018
1Obesity
01/2017
1Fetal Diseases (Embryopathy)
01/2017
1Congenital Abnormalities (Deformity)
01/2017
1Gestational Trophoblastic Disease (Trophoblastic Neoplasms, Gestational)
07/2012
1Choriocarcinoma
07/2012
1Drug Eruptions (Drug Eruption)
11/2011
1Chloracne
11/2011
1Renal Cell Carcinoma (Grawitz Tumor)
11/2011
1Starvation
10/2007
1Genetic Translocation (Chromosomal Translocation)
06/2007
1Habitual Abortion (Recurrent Miscarriage)
12/2006
1Spontaneous Abortion (Miscarriage)
12/2006
1Infarction (Infarctions)
05/2004

Drug/Important Bio-Agent (IBA)

3Proteins (Proteins, Gene)FDA Link
12/2023 - 10/2003
3CollagenIBA
12/2023 - 01/2019
2Dynamins (Dynamin)IBA
12/2023 - 01/2020
2ChondroitinIBA
12/2023 - 01/2022
2NovoSorbIBA
12/2023 - 01/2022
2SiliconesIBA
12/2023 - 01/2022
2Cell-Free Nucleic AcidsIBA
01/2022 - 01/2021
25-hydroxymethylcytosineIBA
01/2022 - 01/2020
2Activins (Activin)IBA
05/2012 - 12/2006
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2003 - 02/2002
1Nitroglycerin (Dynamite)FDA LinkGeneric
12/2023
1NitratesIBA
12/2023
1TamoxifenFDA LinkGeneric
11/2023
1N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase (N-acetylglucosaminyltransferase)IBA
01/2023
1poly-N-acetyllactosamineIBA
01/2023
1Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA
01/2023
1Adapalene (Differin)FDA LinkGeneric
01/2023
1Galectins (Galectin)IBA
01/2023
1Polysaccharides (Glycans)IBA
01/2023
1N-acetylglucosaminyltransferase IGnTIBA
01/2023
1CarcinogensIBA
01/2022
1CytosineIBA
01/2022
1EnzymesIBA
01/2022
1Interleukin-6 (Interleukin 6)IBA
07/2021
1Unithiol (DMPS)IBA
01/2021
1PlasticsIBA
01/2021
1Reactive Oxygen Species (Oxygen Radicals)IBA
01/2020
1GTP Phosphohydrolases (GTPases)IBA
01/2020
1CateninsIBA
01/2020
1DioxygenasesIBA
01/2020
1Imiquimod (Aldara)FDA LinkGeneric
01/2020
1DNA (Deoxyribonucleic Acid)IBA
01/2020
1Collagen Type I (Type I Collagen)IBA
01/2019
1Succinate Dehydrogenase (Fumarate Reductase)IBA
01/2019
1Transcription Factor AP-1 (Transcription Factor AP 1)IBA
01/2019
1Tacrolimus (Prograf)FDA LinkGeneric
01/2017
1MacrolidesIBA
01/2017
1Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
05/2012
1Sorafenib (BAY 43-9006)FDA Link
11/2011
1Aromatic HydrocarbonsIBA
11/2011
1Triglycerides (Triacylglycerol)IBA
10/2007
1RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
06/2007
1FollistatinIBA
12/2006
1Inhibins (Inhibin)IBA
12/2006
1activin AIBA
12/2006

Therapy/Procedure

4Therapeutics
12/2023 - 02/2002
1Airway Management
04/2024
1Skin Transplantation (Skin Grafting)
12/2023
1Artificial Skin
01/2022
1Contraindications
12/2021
1Sutures (Suture)
01/2019
1Catheters
09/2018
1Drug Therapy (Chemotherapy)
07/2012
1Laparotomy
07/2012